Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This Phase 1 trial used Dynamic Contrast-Enhanced MRI to measure the response to etanercept in rheumatoid arthritis. The results were posted after the study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2013-09-17